Literature DB >> 8780647

GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors.

P D Canoll1, J M Musacchio, R Hardy, R Reynolds, M A Marchionni, J L Salzer.   

Abstract

We show that GGF/neuregulin is a mitogen for prooligodendrocytes (O4+/O1- cells), oligodendrocytes (O4+/O1+ cells), and type-2 astrocytes. Heregulin beta 1, another neuregulin isoform, is also mitogenic. The proliferative effect of glial growth factor (GGF) does not require, but is greatly potentiated by, serum factors. GGF also promotes the survival of pro-oligodendrocytes under serum-free conditions. High levels of GGF reversibly inhibit the differentiation and lineage commitment of oligodendrocyte progenitors and, in differentiated cultures, result in loss of O1 and myelin basic protein expression. All three erbB receptors are expressed by progenitors and are activated by GGF; the relative abundance of these receptors changes during differentiation. Finally, cortical neurons release a soluble mitogen for pro-oligodendrocytes that is specifically blocked by antibodies to GGF. These results implicate the neuregulins in the neuronal regulation of oligodendrocyte progenitor proliferation, survival, and differentiation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8780647     DOI: 10.1016/s0896-6273(00)80155-5

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  101 in total

1.  Akt-mediated survival of oligodendrocytes induced by neuregulins.

Authors:  A I Flores; B S Mallon; T Matsui; W Ogawa; A Rosenzweig; T Okamoto; W B Macklin
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

2.  Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10.

Authors:  C Claus Stolt; Stephan Rehberg; Marius Ader; Petra Lommes; Dieter Riethmacher; Melitta Schachner; Udo Bartsch; Michael Wegner
Journal:  Genes Dev       Date:  2002-01-15       Impact factor: 11.361

Review 3.  ErbB-4: a receptor tyrosine kinase.

Authors:  W Zhou; G Carpenter
Journal:  Inflamm Res       Date:  2002-02       Impact factor: 4.575

4.  The oligodendrocyte precursor mitogen PDGF stimulates proliferation by activation of alpha(v)beta3 integrins.

Authors:  Wia Baron; Sanford J Shattil; Charles ffrench-Constant
Journal:  EMBO J       Date:  2002-04-15       Impact factor: 11.598

Review 5.  Neuregulin signaling via erbB receptor assemblies in the nervous system.

Authors:  Sean Murphy; Randy Krainock; Muly Tham
Journal:  Mol Neurobiol       Date:  2002-02       Impact factor: 5.590

6.  Remyelination in vitro following protein kinase C activator-induced demyelination.

Authors:  S Pouly; J M Matthieu; P Honegger
Journal:  Neurochem Res       Date:  2001-06       Impact factor: 3.996

7.  Adenosine: a neuron-glial transmitter promoting myelination in the CNS in response to action potentials.

Authors:  Beth Stevens; Stefania Porta; Laurel L Haak; Vittorio Gallo; R Douglas Fields
Journal:  Neuron       Date:  2002-12-05       Impact factor: 17.173

Review 8.  Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.

Authors:  Chao Deng; Bo Pan; Martin Engel; Xu-Feng Huang
Journal:  Psychopharmacology (Berl)       Date:  2013-02-07       Impact factor: 4.530

9.  Neuregulin 1-erbB2 signaling is required for the establishment of radial glia and their transformation into astrocytes in cerebral cortex.

Authors:  Ralf S Schmid; Barbara McGrath; Bridget E Berechid; Becky Boyles; Mark Marchionni; Nenad Sestan; Eva S Anton
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-20       Impact factor: 11.205

10.  Role of neuregulin-1/ErbB signaling in stem cell therapy for spinal cord injury-induced chronic neuropathic pain.

Authors:  Feng Tao; Qun Li; Su Liu; Haiying Wu; John Skinner; Andres Hurtado; Visar Belegu; Orion Furmanski; Ya Yang; John W McDonald; Roger A Johns
Journal:  Stem Cells       Date:  2013-01       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.